Comments

Aurinia Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

AUPHNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Mon May 12th, before the market open

The most recent conference call was at 8:30 AM, 3 days ago Click to view past webcast

Aurinia Pharmaceuticals (AUPH) Forecast

News Earnings Aurinia Pharmaceuticals (AUPH) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Aurinia Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:AUPH | Benzinga

Explore Aurinia Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AUPH.

Open	$7.85
Close	-
Volume / Avg.	350.12K / 1.43M
Day Range	$7.76 - $7.98
52 Wk Range	5.08 - 10.67
Market Cap	$1.08B
P/E Ratio	29.07
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	9.1%
Days to Cover	11.18

Recent News

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

Aurinia posts Q1 profit and 25% LUPKYNIS sales growth, reports $62.47 million revenue, and reaffirms full-year guidance.

Vandana Singh

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Aurinia Pharmaceuticals reported Q4 earnings of 1 cent per share, beating estimates, with LUPKYNIS sales up 36%.

Vandana Singh

Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.85
Close	-
Volume / Avg.	350.12K / 1.43M
Day Range	$7.76 - $7.98
52 Wk Range	5.08 - 10.67
Market Cap	$1.08B
P/E Ratio	29.07
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	9.1%
Days to Cover	11.18

About

Sector

Healthcare

Industry

N/A

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people...

Got Questions? Ask

Analyze AUPH's market performance

How has AUPH's EPS changed?

How is AUPH's operating margin?

What are analysts' targets for AUPH?

What is AUPH's operating cash flow?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aurinia Pharmaceuticals (AUPH) stock?

You can purchase shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) through any online brokerage.

View our list of the best stock brokerages

Who are Aurinia Pharmaceuticals (AUPH) competitors?

There are no as such competitors for Aurinia Pharmaceuticals.

What is the forecast, or price target, for Aurinia Pharmaceuticals (AUPH) stock?

Aurinia Pharmaceuticals has a consensus price target of $10.75.

What is the current price for Aurinia Pharmaceuticals (AUPH)?

The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $7.97 last updated May 15, 2025 at 11:44 AM EDT.

Does Aurinia Pharmaceuticals (AUPH) pay a dividend?

There are no upcoming dividends for Aurinia Pharmaceuticals.

When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?

Aurinia Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Aurinia Pharmaceuticals (AUPH) going to split?

There is no upcoming split for Aurinia Pharmaceuticals.

What sector and industry does Aurinia Pharmaceuticals (AUPH) operate in?

Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.